Clindamycine Kela 100 mg Tablet
Clindamycine Kela 100 mg Tablet
Authorised
- Clindamycin hydrochloride
Product identification
Medicine name:
Clindamycine Kela 100 mg Tablet
Active substance:
- Clindamycin hydrochloride
Target species:
-
Dog
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Clindamycin hydrochloride114.94/milligram(s)1.00Tablet
Pharmaceutical form:
-
Tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01FF01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Belgium
Available in:
-
Belgium
Package description:
- Clindamycine Kela 100 mg Tablet Box with 8 blisters of 10 tablets
- Clindamycine Kela 100 mg Tablet Box with 2 blisters of 10 tablets
Additional information
Entitlement type:
-
Marketing Authorisation
Marketing authorisation holder:
- KELA Kempisch Laboratorium Kela Laboratoria
Marketing authorisation date:
Manufacturing sites for batch release:
- KELA Kempisch Laboratorium Kela Laboratoria
Responsible authority:
- Federal Agency For Medicines And Health Products
Authorisation number:
- BE-V351687
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Package Leaflet
This document does not exist in this language (English). You can find it in another language below.
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Labelling
This document does not exist in this language (English). You can find it in another language below.
